Start-Up Companies

Choosing a Business Vehicle

The first legal decision every founder must make is also the most consequential: how to organize the business. The form of business vehicle determines how income is taxed, whether owners are personally liable for the business's debts, how capital can be raised, and whether equity can be used to attract and retain employees. The three primary options available to Ontario founders are sole proprietorships, partnerships, and corporations. For the overwhelming majority of serious start-ups, the answer will be a corporation — but understanding why requires understanding the alternatives.

Sole Proprietorships

A sole proprietorship exists whenever an individual carries on business for their own account without the involvement of other persons, except as employees. It is the simplest form of business organization: there are no registration requirements beyond a business name registration (required if the business is carried on under a name other than the proprietor's own name in Ontario), no organizational documents, and no separation between the owner and the business. All income, assets, and liabilities of the business belong to and are owed by the proprietor personally.

The principal advantage of the sole proprietorship is administrative simplicity. Business losses can offset the proprietor's other sources of income in the year they are incurred, and unabsorbed losses may be carried back three years or forward twenty years. However, the defining disadvantage is unlimited personal liability: all of the proprietor's personal assets — home, savings, investments — are exposed to claims arising from the business. There is also no mechanism to issue equity to employees or to attract sophisticated outside capital.

Partnerships

A partnership is the relationship that exists between two or more persons carrying on a business in common with a view to profit. Ontario law recognizes two principal forms: the general partnership and the limited partnership. Unlike a corporation, a partnership is not a separate legal entity — it is a relationship between the partners, governed by the Partnerships Act, R.S.O. 1990, c. P.5.

In a general partnership, each partner is jointly and severally liable for the full extent of the partnership's debts and obligations. This means a single partner's negligent act can expose all partners' personal assets. Rules governing partners' relationships — profit sharing, management rights, dissolution — may be varied by a written partnership agreement, and virtually all general partnerships should have one. Without an agreement, the default rules of the Partnerships Act apply, which often do not reflect the commercial intentions of the parties.

A limited partnership offers a partial solution to the liability problem. A limited partnership has at least one general partner (who bears unlimited liability and manages the business) and one or more limited partners whose liability is capped at the amount of their contribution. Limited partners must not participate in management or they risk losing their limited liability protection. The limited partnership structure is commonly used for investment funds and real estate ventures, but is less suitable for operating start-ups.

Partnerships are tax-transparent: the partnership does not pay income tax itself; instead, each partner includes their allocated share of partnership income or loss in their personal income, calculated and reported each year. This can be advantageous in the early loss-making years of a business when individual partners have other income to offset.

Why Incorporate?

The corporation's defining features — separate legal personality and limited liability — are what make it the vehicle of choice for virtually every business with growth ambitions. A corporation is a legal person distinct from its shareholders. It can own property, enter contracts, sue and be sued, and carry on business in its own name. Its shareholders are not personally liable for the corporation's debts and obligations beyond the amount they invested in their shares.

Incorporating in Canada

Canadian founders can incorporate either federally under the Canada Business Corporations Act, R.S.C. 1985, c. C-44 (CBCA) or provincially — most commonly in Ontario under the Ontario Business Corporations Act, R.S.O. 1990, c. B.16 (OBCA). The choice between them is one of the first practical legal decisions a founder must make.

CBCA vs. OBCA: The Choice

For most Ontario-based start-ups, the OBCA is a practical and cost-effective choice. CBCA incorporation is often preferred where the company anticipates significant operations in multiple provinces from the outset, where U.S. venture capital investors are involved at an early stage, or where the founders wish to maximize flexibility for future share structures. The CBCA also provides somewhat greater flexibility in certain share class designs and shareholder agreement provisions.

Articles of Incorporation

The articles of incorporation are the constitutional document of the corporation, filed with Corporations Canada (CBCA) or the Ontario government (OBCA) to bring the corporation into existence. The key contents of the articles include:

• Corporate name — either a distinctive word name (requiring a NUANS name search to confirm availability and ensure no confusing similarity with existing names or trademarks) or a numbered corporate name (e.g., "1234567 Ontario Inc."), which involves no search but carries no brand identity.
• Registered office — the address at which official documents and legal process will be served on the corporation. For many start-ups this is initially the lawyer's office or the founder's address.
• Share capital — the classes of shares the corporation is authorized to issue, their number (which may be unlimited), and the rights, privileges, restrictions, and conditions attached to each class.
• Number of directors — either a fixed number or a minimum and maximum range. A range is preferable for most start-ups as it provides flexibility to add board seats as the company grows.
• Transfer restrictions — a restriction on the right to transfer shares is the most important condition for maintaining private issuer status under securities legislation. Articles of incorporation for private companies invariably include a transfer restriction clause.
• Restrictions on business — most start-up articles contain no restriction on the corporation's business, preserving maximum flexibility.

Share Structure

The share structure is one of the most important planning decisions at incorporation. A thoughtful share structure minimizes tax on the founder's exit, accommodates investor preferred shares, and provides flexibility for employee equity plans. Most start-up corporations are incorporated with at least two classes of shares:

• Common shares — the founders' shares, carrying voting rights, participation in earnings after preferred distributions, and residual participation in any liquidation or sale proceeds after preferred claims are satisfied. Common shares are typically issued at a nominal price at incorporation.
• Preferred shares — issued to investors at later rounds, structured with the economic rights investors require: liquidation preferences, dividend priorities, anti-dilution protection, and conversion rights. The detailed terms of each preferred series are set out in the articles or in a schedule to the articles.

Some start-ups also create a separate class of common shares — sometimes called "Class B" or "restricted voting" shares — for the employee share option plan (ESOP) pool, allowing options to be granted without diluting the founders' voting control. Careful planning at incorporation can also establish the share capital in a way that preserves the founders' eligibility for the Lifetime Capital Gains Exemption (LCGE) on a qualifying disposition.

Post-Incorporation Steps

Incorporation creates the legal shell; the post-incorporation organization steps give the corporation its governance infrastructure. A properly organized corporation should have the following in place immediately after incorporation:

• By-laws — the internal rules governing the corporation's operations, including notice requirements for meetings, quorum, voting procedures, and the powers of officers. By-laws are adopted by the directors and confirmed by the shareholders.
• Directors' organizational resolutions — the first meeting of the board formally appoints officers, adopts the by-laws, approves the form of share certificates, establishes the fiscal year, authorizes the opening of a bank account, and issues shares to the founders.
• Share issuances — shares are issued and share certificates (or electronic equivalents) are prepared. Every share issuance must be recorded in the corporate minute book along with the consideration received.
• Minute book — a physical or electronic record containing the articles, by-laws, all shareholder and director resolutions, share certificates, and the share register. The minute book is the authoritative record of the corporation's governance history and is essential for due diligence in any financing, acquisition, or IPO.
• Shareholders' agreement — ideally executed concurrently with or immediately after incorporation, before outside capital is raised. See Section 5 below.
• IP assignment agreements — all pre-incorporation intellectual property created by the founders must be formally assigned to the corporation, along with a waiver of moral rights where applicable. Failure to do this is among the most common and dangerous oversights at the formation stage.

Corporate Governance for Start-Ups

Board Composition

The board of directors is the governing body of the corporation, responsible for overseeing management, approving major decisions, and ensuring the corporation's long-term interests are served. For a start-up, board composition is a strategic question that evolves significantly over the company's lifecycle. The founders will typically all serve as directors at inception, but as outside capital is raised and the company matures, board composition must change to reflect the interests of new stakeholders and to attract the independent judgment that sophisticated investors and regulators require.

There are four ways to allocate board control in an early-stage company:

• Founder-controlled board — gives the founders majority board representation. This preserves control but significantly impairs the ability to raise capital from sophisticated investors, who will rarely invest in a company where they have no meaningful board voice. It also makes it impossible to resolve founder disputes through a neutral governing body.
• Investor-controlled board — majority board positions given to a particular group of investors. Clearly not in founders' interests, particularly with respect to the interests of other constituencies (friends, family, early employees) who could be disregarded by such a board.
• Balanced board with independent swing votes — the configuration most consistently recommended for growth companies. Founders and significant investors each have representation, but the balance of power is held by directors independent of both groups. Independent directors moderate demands, provide a forum for dispute resolution, and attract credibility with subsequent investors.
• Performance-contingent composition — board seats shift on the achievement (or failure) of milestones. This distorts decision-making around milestone achievement rather than value creation and is generally discouraged.

Directors and Officers

Under both the CBCA and OBCA, the business and affairs of a corporation are managed by or under the direction of the board of directors. The statutory framework distinguishes between directors (elected by shareholders) and officers (appointed by the directors). Both the CBCA and OBCA impose eligibility requirements on directors: individuals must be adults (18 years or older), of sound mind, not bankrupt, and — for CBCA and OBCA corporations — a specified proportion must be resident Canadians.

Officers — the chief executive officer, chief financial officer, secretary, and any other officers designated by the by-laws — are agents of the corporation whose authority flows from their appointment and from the apparent scope of their role. The CEO, in practice, is the primary point of contact between the board and the corporation's operations, and the scope of their actual authority is frequently broader than what is formally documented.

By-Laws and Resolutions

By-laws are the corporation's internal operational rules. They govern matters such as the calling and conduct of meetings, the number of directors constituting quorum, voting thresholds for various decisions, signing authorities for contracts and banking, and the roles and powers of officers. Start-up companies typically adopt a standard general by-law at incorporation, supplemented by the more specific governance provisions in the shareholders' agreement.

Directors and shareholders act through resolutions — formal decisions adopted at meetings or, in the case of private companies, by written resolution signed by all directors or shareholders entitled to vote. Properly maintained resolutions are the backbone of the minute book and are essential evidence of the corporation's governance decisions for any future due diligence process.

Director and Officer Duties and Liability

Directors and officers of start-up corporations are subject to the same legal duties as those of large public companies, even though the practical governance infrastructure is simpler. These duties arise from the corporate statutes (CBCA and OBCA), the common law, and a growing body of other legislation. Founders who serve as directors and officers are often surprised to discover the breadth of their personal exposure.

Fiduciary Duty

Every director and officer of a corporation owes a fiduciary duty to the corporation — not to individual shareholders, not to themselves, and not to any particular stakeholder group. The fiduciary duty has two principal components: the duty of loyalty and the duty to avoid conflicts of interest.

The duty of loyalty requires directors and officers to act honestly and in good faith, with a view to the best interests of the corporation. This means putting the corporation's interests ahead of their own personal interests when the two conflict. Where a director or officer has a material interest in a proposed transaction to which the corporation is a party, they must disclose that interest to the board and, in most cases, refrain from voting on the matter. Failure to disclose and obtain board approval is a breach of fiduciary duty, regardless of whether the transaction was actually fair to the corporation.

The duty to avoid conflicts of interest includes the prohibition on usurping corporate opportunities — a director or officer who learns of a business opportunity through their position with the corporation may not personally take that opportunity without first offering it to and having it declined by the corporation. This prohibition applies even after the director leaves office in respect of opportunities that were maturing while they held their position.

Duty of Care

Directors and officers must exercise the care, diligence, and skill that a reasonably prudent person would exercise in comparable circumstances. Under the CBCA and OBCA, this standard requires active engagement: directors are expected to attend meetings, review financial information, ask questions, seek expert advice when appropriate, and take steps to stay informed about the corporation's affairs.

The duty of care is tested against an objective reasonable person standard rather than a subjective assessment of the director's own abilities, but the standard is calibrated to the director's actual expertise — a director with a finance background may be held to a higher standard on financial matters. The business judgment rule provides directors with protection from liability for decisions that turn out badly, provided the decision was made in good faith, on a reasonably informed basis, and was within the range of reasonable business choices. Canadian courts have generally been reluctant to second-guess bona fide business decisions made through a proper governance process.

Statutory Liability

Beyond the common law duties, directors face significant personal liability under various statutes that operate independently of whether they acted in good faith. The key areas of statutory liability for start-up directors include:

• Employment obligations — Under the CBCA and OBCA, directors are personally jointly and severally liable for up to six months' wages owed to employees if the corporation fails to pay. Similar obligations arise under Ontario's Employment Standards Act, 2000 for vacation pay, overtime, and termination pay. This liability applies even to directors who played no role in the compensation decision.
• Tax obligations — Directors may be personally liable for unremitted source deductions (income tax, CPP, EI) and HST/GST if the corporation fails to remit and the director did not exercise due diligence to prevent the failure. The Canada Revenue Agency pursues director liability assessments aggressively in start-up failures.
• Environmental liability — Directors may be held personally liable under provincial environmental legislation for the corporation's environmental violations if they directed, authorized, assented to, or participated in the contravening conduct.
• Securities violations — Directors of companies that make misrepresentations in continuous disclosure documents may face personal liability under the secondary market liability regime of provincial securities legislation.

Indemnification and D&O Insurance

Both the CBCA and OBCA authorize corporations to indemnify directors and officers against liabilities arising from their duties to the corporation, provided the director or officer acted honestly and in good faith with a view to the best interests of the corporation. Indemnification provisions are typically included in the corporation's by-laws and may be supplemented by a formal indemnification agreement between the director and the corporation.

However, a contractual indemnity is only as valuable as the corporation providing it — a start-up that fails leaves its indemnified directors exposed. Directors' and Officers' (D&O) insurance fills this gap by providing coverage for claims against individual directors and officers arising from alleged wrongful acts in their corporate roles. Even early-stage private companies should consider D&O insurance, particularly once outside investors join the board. Venture capital investors routinely require D&O coverage as a condition of closing. The policy covers defence costs and, subject to exclusions, any damages or settlement arising from covered claims.

Shareholders' Agreements

Why Every Start-Up Needs One

A shareholders' agreement is the most important legal document a start-up will have until its first institutional financing. It governs the relationship among the founders — and, once investors arrive, among all shareholders — on the issues that matter most and that statutes and articles alone do not adequately address: what happens when a founder leaves the company, who controls the board and how decisions are made, what restrictions apply to share transfers, and how disputes are resolved.

The single most dangerous time to negotiate a shareholders' agreement is during a dispute — yet that is precisely when many start-up founders first discover they don't have one. A shareholders' agreement must be negotiated when the relationship among founders is collaborative and the parties are aligned in wanting the company to succeed. Waiting until a co-founder wants to leave, until an investor objects to a transaction, or until a deadlock develops makes negotiation combative and the outcome unpredictable.

Founder Vesting

Founder vesting is among the most important provisions in a start-up shareholders' agreement, and it is one of the most often resisted and least understood. Vesting is the mechanism by which a departing founder forfeits all or a portion of their shares if they leave the company before their contribution has been fully earned. Without vesting, a co-founder can leave on day one — taking their full shareholding with them — while the remaining founders continue building the company that supports that share value.

The typical vesting schedule provides for vesting over four years, with a one-year cliff (meaning no shares vest in the first year) and monthly vesting thereafter. On a voluntary departure or termination for cause before the cliff, the founder forfeits all unvested shares. On departure after the cliff, unvested shares are forfeited and vested shares are retained. The forfeited shares are typically repurchased by the corporation or the remaining shareholders at a nominal price — often original issue price — rather than fair market value, reflecting the economic penalty for early departure.

Share Transfer Restrictions

Share transfer restrictions serve multiple purposes: they maintain the corporation's private issuer status under securities legislation; they prevent unwanted third parties from becoming shareholders; and they give existing shareholders a degree of control over who their co-shareholders will be. The principal mechanisms are:

• Right of first refusal (ROFR) — a shareholder wishing to sell their shares must first offer them to the corporation and/or the other shareholders at the proposed sale price and terms. Only if the existing shareholders decline to exercise the ROFR may the shares be sold to the third party, and only on the same terms as offered to the existing shareholders.
• Board approval right — share transfers require the approval of the board of directors, which may be withheld on reasonable grounds including concerns about the identity or suitability of the proposed transferee.
• Permitted transfers — transfers to a holding company wholly owned by the transferring shareholder, or to an RRSP or TFSA for the shareholder's benefit, are typically carved out from the ROFR and approval requirements.

Control Provisions

The shareholders' agreement typically governs how key decisions are made and who controls the corporation at each stage of its development. Common control provisions include:

• Matters requiring shareholder approval — decisions of fundamental importance that require shareholder consent beyond what the corporate statute mandates, such as changes to the business plan, issuance of new shares outside an approved plan, and entry into major contracts above a specified dollar threshold.
• Matters requiring investor approval — once preferred shareholders join the cap table, the agreement will typically require the approval of a specified percentage of preferred shareholders for a defined list of matters adversely affecting their rights, including: changes to the articles, declaration of dividends, creation of new share classes ranking ahead of the preferred, any merger, amalgamation, or sale of all or substantially all of the assets, and dissolution.
• Board nomination rights — the agreement specifies which shareholders have the right to nominate one or more directors, and the obligation of other shareholders to vote their shares in favour of those nominees.

Exit and Dispute Mechanisms

A well-drafted shareholders' agreement anticipates the most common causes of breakdown and provides contractual mechanisms for resolution that do not require immediate recourse to litigation. The principal mechanisms are:

• Drag-along rights — allow the holders of a specified majority of shares (typically a combination of founders and preferred shareholders) to compel all other shareholders to sell their shares on the same terms in a bona fide third-party transaction. Drag-along rights prevent minority shareholders from blocking a sale that the majority wishes to complete.
• Tag-along rights (co-sale rights) — the obverse of drag-along rights: any shareholder who proposes to sell shares to a third party must allow other shareholders to participate in the sale on the same terms, pro rata. This prevents controlling shareholders from selling to a buyer who will not extend the same opportunity to minority holders.
• Shotgun clause (buy-sell provision) — a dispute resolution mechanism applicable in many two-founder companies. Either shareholder may trigger the clause by offering to buy the other's shares at a specified price per share. The recipient must either sell at that price or buy the triggering shareholder's shares at the same price. The symmetry of the clause incentivizes the offering shareholder to set a fair price.
• Mediation and arbitration — shareholders' agreements typically require disputes to be submitted to mediation before court proceedings, and many provide for binding arbitration as the ultimate dispute resolution mechanism, with the arbitration conducted privately and confidentially.

Capital Raising and Securities Law

Debt vs. Equity

Capital raised by a corporation comes in two fundamental forms: debt and equity. The choice between them — and the use of hybrid instruments that share features of both — is a central financial and legal decision at every stage of a start-up's growth. Understanding the fundamental differences between debt and equity is essential before entering into any capital-raising transaction.

Prospectus Exemptions

Any distribution of securities in Ontario requires a prospectus unless an exemption is available. A prospectus is a comprehensive disclosure document — expensive and time-consuming to prepare — that gives investors full, true, and plain disclosure of all material facts before they invest. For private start-ups, a prospectus is never used in the early stages; instead, founders and companies rely on one or more of the prospectus exemptions found in NI 45-106 — Prospectus Exemptions to distribute shares to investors without the obligation to file a prospectus.

Convertible Instruments: SAFEs and Notes

Early-stage start-ups frequently raise their first outside capital using convertible instruments rather than issuing shares at a fixed valuation. A convertible instrument is a debt or quasi-equity security that converts into shares of the company at a future financing round, at a discount to the price paid by investors in that round. Convertible instruments are popular because they defer the difficult question of the company's valuation until there is more information to price it — the valuation is effectively set at the next priced round.

Two instruments dominate the Canadian start-up market:

• Convertible notes — a form of debt that converts into shares at the next qualifying financing round. The note bears interest (typically 6–8%) and has a maturity date (typically 12–24 months). If the company raises a qualifying round before maturity, the note converts into shares of the new series at the round's price, subject to a discount (commonly 15–20%) and a valuation cap (a ceiling on the valuation at which the note converts, protecting early investors from excessive dilution if the company achieves a very high valuation at the next round).
• SAFEs (Simple Agreements for Future Equity) — a U.S.-originated instrument developed by Y Combinator, increasingly used in Canada. Like a convertible note, a SAFE converts at the next qualifying financing at a discount and/or cap-protected price. Unlike a convertible note, a SAFE is not debt — it has no interest rate, no maturity date, and no repayment obligation. It is simply an agreement to issue shares in the future. This makes SAFEs simpler and founder-friendly, though they may not be treated as debt for accounting purposes and their insolvency treatment differs from convertible notes.

Angel and Early-Stage Financing

Love Money and Friends & Family

The first external capital raised by most start-ups comes from the founders' own networks — family members, close friends, and professional acquaintances who invest based on personal relationships rather than rigorous commercial analysis. These "love money" investments are the most accessible form of early capital but carry their own legal and practical risks.

From a securities law perspective, distributions to family members and close personal contacts may qualify under the Family, Friends and Business Associates (FFBA) exemption under NI 45-106, provided the relationship meets the qualifying criteria. The FFBA exemption is personal to the individuals: a director or officer of the company must have the requisite relationship with each investor, and the exemption is not available simply because an investor is known to one of the founders' employees or casual acquaintances.

Practically, mixing personal relationships with investment creates real risks that founders should understand. Family investors who lose their capital may create lasting personal damage to the relationship. They may also have unrealistic expectations about returns, timelines, or their role in the company. A properly documented subscription agreement — setting out the terms of the investment, the risks, and the lack of any guarantee of return — is essential even for love money investments.

Structure of Angel Financings

Angel investors are high-net-worth individuals who invest their own capital in early-stage companies, typically at a stage before professional venture capital funds are interested. Angels occupy a crucial role in the Canadian start-up ecosystem, bridging the gap between family funding and institutional rounds. The typical angel investor qualifies as an accredited investor under NI 45-106 and invests between $25,000 and $500,000 per deal, often syndicating with other angels through networks such as the National Angel Capital Organization (NACO) member groups.

Angel investments are typically documented using either:

• A subscription agreement — a direct share purchase at a negotiated price per share, with representations and warranties about the company's capitalization, intellectual property, and material contracts. Simpler and more common at the earliest stages.
• A convertible note or SAFE — as described above, deferring the valuation question to the next institutional round. Many angel groups and individual angels have standardized their investment documents to reduce transaction costs.

Offering Memoranda

A company wishing to raise capital from a broader base of non-accredited investors — including through the OM exemption available to retail investors subject to investment limits — must prepare and deliver a prescribed offering memorandum (OM) before accepting subscriptions. An OM is not a prospectus: it is a less formal document, but it must contain certain prescribed information about the company and its business, the terms of the offering, and the use of proceeds, and it must include a prescribed risk acknowledgement form signed by each purchaser. Purchasers under the OM exemption have a right to rescind their subscription within 48 hours of receiving the OM.

Critically, the OM must not contain a misrepresentation — a statement that is untrue in a material respect, or an omission of a material fact. If an OM contains a misrepresentation, purchasers have a statutory right of rescission (for purchasers who still hold their securities) or damages (for those who have sold). This right runs against the issuer, its directors, and anyone who signed the OM. The misrepresentation right creates significant personal exposure for directors who approve OMs without conducting adequate due diligence on the accuracy of the document's contents.

Venture Capital Financing

Overview and Fund Objectives

Venture capital (VC) is professionally managed capital raised from institutional investors — pension funds, university endowments, corporations, and high-net-worth individuals — and deployed into early-stage, high-growth companies with the expectation of substantial returns. VC funds are typically structured as limited partnerships with a finite life of ten years, managed by a general partner who sources, evaluates, and manages investments. The fund's economics typically consist of a management fee (2% of committed capital per year) and carried interest (typically 20% of profits above a preferred return threshold).

Venture capital investors have a fundamentally different investment thesis from angels and strategic investors. A VC fund expects the vast majority of its portfolio companies to fail or return minimal capital — the fund's economics depend on a small number of "home runs" that return many multiples of the invested capital. This asymmetric return expectation explains the contractual terms VC investors require: they are not seeking a reasonable return on a successful business but the maximum possible upside from the small fraction of investments that achieve exceptional outcomes.

Staged Investment

By far the most powerful mechanism of control used by VC investors is the practice of providing companies with only enough capital to reach the next definable milestone. Unlike bank loans, which typically disburse funds in a single tranche, VC investments are staged across multiple rounds — seed, Series A, Series B, and so on — each contingent on the company meeting agreed milestones.

Staging serves the VC investor in several ways. It limits the capital at risk at any given time. It provides ongoing opportunities to assess management and business model before committing the full anticipated investment. And — most significantly — the prospect of the next round being withheld gives VC investors enormous ongoing leverage over management decisions. A company that has exhausted its current round of capital and needs a further financing to survive is structurally dependent on the goodwill of its existing investors, particularly when right of first refusal provisions give those investors a near-monopoly over follow-on financings.

Experienced founders plan their fundraising strategy to minimize this vulnerability. They target milestone valuations far enough in the future that a single round of capital will last 18 to 24 months, and they build relationships with multiple potential future investors rather than relying exclusively on their existing investor group.

Preferred Share Terms

Institutional venture capital investors invest almost universally through preferred shares rather than common shares. Preferred shares give investors economic and governance rights that common shares do not provide. The key preferred share terms negotiated in a VC financing include:

Liquidation Preferences

A liquidation preference gives preferred shareholders a prior claim on the corporation's assets or sale proceeds before any distributions are made to common shareholders. The preference may be structured in three ways:

• Non-participating preferred — on a liquidation or sale, the preferred shareholder receives back their invested capital (plus any accrued dividends) and then chooses either to take their liquidation amount or to convert to common and participate in the remaining proceeds. This structure is common in more founder-friendly deals.
• Fully participating preferred — the preferred shareholder receives their liquidation amount and then participates alongside the common shareholders in any remaining proceeds on a converted basis. Also called "double-dipping," this structure significantly disadvantages founders in a modest exit.
• Capped participating preferred — the preferred shareholder receives their liquidation amount and participates in the remaining proceeds up to a specified multiple (e.g., 2x or 3x) before reverting to non-participating. A reasonable middle ground widely used in Canada.

Anti-Dilution Protection

Anti-dilution provisions protect preferred shareholders from the economic dilution they would suffer if the company subsequently issues shares at a price below the price they paid — a "down round". The two main types are:

• Weighted average anti-dilution — adjusts the preferred share conversion price based on a weighted average of the original price and the new lower price, taking into account the number of new shares issued. This is the standard in most Canadian venture financings and is considered fair to both founders and investors.
• Full ratchet anti-dilution — adjusts the conversion price to the new lower price regardless of the number of shares issued at the lower price. This is extremely punitive for founders and is generally only accepted in investor-friendly markets or distressed circumstances.

Conversion Rights

Every series of preferred shares carries a right to convert into common shares at a specified conversion ratio (typically 1:1, subject to adjustment for anti-dilution). Conversion rights are important because preferred shares convert automatically on a qualifying IPO — allowing the preferred shareholders to participate as common shareholders in the public market — and can be voluntarily exercised by the investor at any time if common share participation is more economically advantageous than remaining as preferred.

Control Provisions and Covenants

Beyond the economic terms of their preferred shares, VC investors obtain significant operational and governance rights through the subscription agreement, investor rights agreement, and shareholders' agreement. These include:

• Protective provisions (veto rights) — a list of specified matters that cannot be done without the approval of a specified percentage of preferred shareholders, regardless of what the common shareholders wish. These typically include: altering the rights of the preferred shares, creating new share classes with senior or equal rights, increasing the authorized number of preferred shares, paying dividends on common shares, redeeming or repurchasing shares other than pursuant to approved buyback programs, and selling all or substantially all of the assets or agreeing to a merger.
• Information rights — the right to receive audited annual financial statements, unaudited quarterly statements, an annual budget, and, for major investors, notice of material developments between reporting periods. Information rights are essential for VC investors who must report performance to their own limited partners.
• Pre-emptive rights (pro-rata rights) — the right of existing investors to participate in future financing rounds pro rata to their current ownership, maintaining their percentage ownership in the company. This is a standard right protecting investors from dilution in subsequent rounds.
• Right of first refusal (ROFR) — a VC firm will typically negotiate a ROFR on any proposed transfer of preferred shares by a co-investor, in addition to the ROFR provisions in the general shareholders' agreement applying to all shareholders.

Co-Sale, Drag-Along, and Exit Rights

VC investors have a defined investment horizon — typically five to seven years from investment — and their entire economic model depends on achieving a liquidity event that returns capital to the fund. The legal mechanisms for managing the timing and terms of an exit are among the most heavily negotiated provisions in VC financings:

• Drag-along rights — enable the holders of a specified majority of shares to compel all other shareholders to sell on the same terms in an approved sale. This prevents a small group of minority shareholders (including founders with small remaining stakes or early angel investors) from blocking a sale that the majority and the VC investors wish to complete.
• Co-sale rights — allow VC investors to participate alongside founders in any sale of a significant number of founder shares to a third party. This prevents founders from engineering a personal exit at a premium that is not available to other shareholders.
• Retraction rights and put options — where the VC investment has a defined term, the preferred shares may carry a retraction right (a right to require the corporation to repurchase them) after a specified period. These rights are valuable as a backstop but are often impractical to enforce if the company lacks cash.
• Registration and piggyback rights — in the event of an IPO, VC investors have the right to register their shares for sale in the public market alongside the company's shares. Piggyback rights allow investors to include their shares in any registration statement the company files, reducing their reliance on the company's timing for their exit.

Equity Compensation

Equity-based compensation is the start-up's primary tool for attracting and retaining talent in an environment where cash compensation cannot compete with established employers. The ability to issue stock options, restricted share units, and other equity instruments is one of the key advantages of the corporate form over sole proprietorships and partnerships. However, equity compensation involves significant legal and tax complexity that must be managed carefully from the outset.

Stock Options

A stock option is the right to purchase a specified number of shares in the corporation at a pre-determined price (the "exercise price" or "strike price") during a specified period. Options are the most common form of equity compensation for start-up employees and are typically granted through a formal Employee Stock Option Plan (ESOP) that is approved by the board and the shareholders.

The key terms of a stock option grant include:

• Exercise price — the price at which the employee may purchase the shares. For tax purposes, the exercise price should generally be set at or above the fair market value of the shares at the time of the grant. Setting the exercise price below fair market value can trigger immediate income tax consequences.
• Vesting schedule — options typically vest over four years, with or without a one-year cliff, on the same or similar terms as founder vesting. Unvested options are typically forfeited on termination of employment.
• Term — the period during which vested options may be exercised, typically ten years from the grant date, subject to early expiry on termination of employment.
• Option pool — the total number of shares reserved under the ESOP. Most early-stage companies reserve 10–20% of their fully diluted share count for the option pool, which is refreshed as necessary before institutional financing rounds.

Under the Income Tax Act, an employee who exercises options on shares of a Canadian-controlled private corporation (CCPC) is eligible for a deferral of the employment benefit until the shares are sold, and may be eligible for the 50% deduction on the employment benefit (effectively taxing it at capital gains rates) if the shares are held for at least two years after exercise and the option was granted at fair market value. This CCPC option deduction is a significant tax advantage over options in public companies.

Restricted Share Units

A restricted share unit (RSU) is a right to receive a share (or cash equal to a share's value) at a future date, subject to vesting conditions. Unlike a stock option — which has value only if the share price exceeds the exercise price — an RSU has value as long as the underlying shares have any value at all. RSUs are increasingly used in later-stage private companies and in public companies as an alternative to stock options.

For tax purposes, RSUs trigger income tax at the time of vesting (when the shares are delivered or the cash is paid), at which point the full value of the shares received is included in employment income. Deferred Share Units (DSUs) operate similarly but with deferral to the date of departure or retirement, and are primarily used for non-employee directors. The tax treatment of RSUs and DSUs in private companies requires careful structuring to avoid triggering immediate income inclusions, particularly where shares are subject to transfer restrictions.

Employee Share Plans

Beyond options and RSUs, some start-ups implement direct share purchase plans allowing employees to acquire shares directly at a preferential price or through payroll deduction. These are subject to securities law considerations — the issuance of shares to employees requires an applicable prospectus exemption. Under NI 45-106, there is a specific Employees, Directors, Senior Officers and Consultants exemption permitting distributions to these persons provided they are employed or engaged by the issuer and acquire shares for their own account. The exemption is commonly used to allow employees to purchase shares directly or to have options exercised into shares without a prospectus.

Tax Considerations for Start-Ups

Corporate vs. Personal Tax

One of the principal financial advantages of incorporating is access to the corporate tax rate rather than personal marginal rates. Active business income of a Canadian-controlled private corporation (CCPC) that qualifies for the small business deduction under the Income Tax Act is taxed at a combined federal-provincial rate of approximately 12.2% in Ontario (as of 2025) on the first $500,000 of active business income annually. The top marginal personal income tax rate in Ontario exceeds 53%. The rate differential creates a significant tax deferral advantage: income earned and retained inside a corporation is taxed at the corporate rate, with personal tax payable only when the income is eventually paid out as dividends or salary. This deferral can be reinvested in the business for years before it is subject to personal tax.

The small business deduction is available to CCPCs — corporations that are not controlled by public corporations or non-residents, with a prescribed level of Canadian ownership. For most start-up companies founded by Canadian residents, CCPC status is the default. As the company raises capital from U.S.-based VC funds or other non-resident investors, CCPC status must be monitored carefully, as its loss eliminates access to the small business deduction and certain SR&ED credits.

SR&ED Tax Incentives

The Scientific Research and Experimental Development (SR&ED) program is the single most significant tax incentive available to technology start-ups in Canada and is one of the most generous R&D tax credit regimes among OECD countries. SR&ED provides refundable investment tax credits (ITCs) for eligible expenditures on scientific research and experimental development carried on in Canada.

For a qualifying CCPC with prior-year taxable income below the prescribed threshold, the federal refundable ITC rate on eligible SR&ED expenditures is 35%, refundable in cash even where the corporation has no taxes payable — a critical feature for pre-revenue start-ups. Above the threshold, the general corporate rate of 15% applies on a non-refundable basis. Ontario provides a complementary provincial R&D credit (Ontario Innovation Tax Credit) of 8% for qualifying smaller CCPCs.

Eligible SR&ED expenditures include salaries and wages of employees engaged in SR&ED, contractor costs (at a reduced inclusion rate), and certain material costs. Expenditures must relate to work aimed at advancing scientific knowledge or achieving technological advancement in a specific, defined sense — not all product development qualifies. SR&ED claims are filed with the CRA and are subject to review; companies with significant claims should maintain contemporaneous documentation of their R&D activities.

Lifetime Capital Gains Exemption

The Lifetime Capital Gains Exemption (LCGE) allows an individual to shelter a substantial amount of capital gains from the sale of Qualified Small Business Corporation (QSBC) shares from income tax. For 2025, the LCGE for QSBC shares is approximately $1.25 million per individual. In a company with multiple founder shareholders, each can claim the LCGE on their own qualifying gain.

To qualify, the shares must be shares of a CCPC:

• At least 90% of the fair market value of the assets of the corporation (and each corporation connected to it) must be used principally in an active business carried on primarily in Canada at the time of the sale;
• Throughout the 24 months immediately before the sale, more than 50% of the FMV of the corporation's assets must have been used principally in an active business carried on primarily in Canada; and
• The shares must not have been owned by any person other than the individual (or a related person or partnership) throughout the 24 months before the sale.

The 24-month holding and asset use conditions require planning well in advance of a potential sale. Excess cash or passive investments held in the corporation at the time of the sale can disqualify shares from QSBC status. Founders who anticipate a sale should review their LCGE eligibility at least 24 months before the anticipated closing and take steps to purify the corporation by distributing excess passive assets if necessary.

Liquidity Events

A liquidity event is a transaction through which shareholders convert their equity in the company into cash or publicly tradeable securities. For most start-up shareholders — founders, employees, and investors alike — the liquidity event is the culmination of years of work and the occasion on which the economic value they have created is realized. The three principal liquidity event structures are the sale of the business, the initial public offering, and the merger or amalgamation.

Sale of Business: Asset vs. Share Sale

The most common liquidity event for Canadian start-ups is the sale of the business to a strategic acquiror or a private equity buyer. The sale is structured either as a share sale (the acquiror purchases shares of the corporation from the shareholders) or an asset sale (the corporation sells its business assets to the acquiror, and the corporation's shareholders receive the proceeds on a subsequent dissolution or distribution).

In practice, most transactions are structured as share sales, with a corresponding price adjustment or indemnification mechanism through which the buyer's tax disadvantage is offset. The key transactional documents in a private company acquisition include a letter of intent or term sheet, a purchase agreement (with representations and warranties, conditions to closing, and post-closing covenants), a disclosure schedule, and ancillary agreements including non-competition and non-solicitation agreements binding the founders.

Large acquisitions of Canadian businesses may also require review under the Competition Act (if thresholds for a pre-merger notification are met) and the Investment Canada Act (if the buyer is a non-Canadian and the transaction exceeds prescribed enterprise value thresholds, or involves businesses in sensitive sectors).

Initial Public Offerings

An initial public offering (IPO) involves the corporation distributing its shares to the public through a prospectus, becoming a reporting issuer, and listing those shares on a stock exchange — typically the TSX or TSX Venture Exchange for Canadian issuers. The IPO provides the corporation with access to permanent public capital markets and provides existing shareholders with a liquid market in which to eventually sell their holdings.

The IPO process is lengthy and expensive. A full prospectus must be prepared in compliance with applicable securities regulation, including audited financial statements, comprehensive disclosure of the business and risk factors, and certification by officers and directors. Underwriters are engaged to market the offering to institutional and retail investors, and their fees — typically 5–7% of gross proceeds — represent a significant transaction cost.

The decision to go public involves trade-offs beyond cost. Reporting issuers face a permanent burden of ongoing disclosure — continuous disclosure obligations, executive compensation transparency, and the scrutiny of public shareholders — that limits the flexibility founders enjoyed as private company operators. Trade secrets and competitive information that was confidential must now be disclosed in public documents. The founders' ability to make decisions privately and quickly is permanently constrained by the obligations owed to public shareholders. For many successful start-ups, a sale to a strategic buyer is a more efficient and less disruptive exit path than an IPO.

Mergers and Amalgamations

An amalgamation is a statutory procedure under the CBCA or OBCA by which two or more corporations combine into a single continuing corporation. In the start-up context, amalgamations are most commonly used in triangular mergers — a structure widely used in acquisitions, particularly those involving U.S. buyers. In a triangular merger, the acquiror creates a subsidiary, the subsidiary is amalgamated with the target company, and the consideration paid by the acquiror for the target's shares is shares of the acquiror (a "share-for-share" transaction) or cash. The shareholders of the target company receive the acquiror's shares or cash in exchange for their shares in the target — effectively a sale of the business accomplished through a corporate law procedure rather than a direct share purchase.

Amalgamations require shareholder approval — typically by special resolution (two-thirds of votes cast) — and provide a dissent and appraisal right allowing minority shareholders who oppose the transaction to require the corporation to repurchase their shares at fair value. The dissent right is an important shareholder protection in contested amalgamations but is also a mechanism that minority shareholders can use to extract value in transactions where the offered price is perceived as inadequate.